Drug Trial Radar · NCT00006392
S0000 Selenium and Vitamin E in Preventing Prostate Cancer
Last checked: Nov 20, 2026Latest source record: Nov 20, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
35,533
Actual
Start
Jul 2001
Primary completion
May 2011
Study completion Sep 2012
Sponsor
- Lead sponsor
- SWOG Cancer Research NetworkResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI); Eastern Cooperative Oncology Group; Cancer and Leukemia Group B; NCIC Clinical Trials Group
- First posted
- Jan 27, 2003
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- Male only, from 50 years, up to 120 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development of cancer. It is not yet known which regimen of selenium and/or vitamin E may be more effective in preventing prostate cancer. PURPOSE: Randomized phase III trial to determine the effectiveness of selenium and vitamin E, either alone or together, in preventing prostate cancer.
Conditions
- Prostate Cancer
Interventions
Vitamin EDrug
400 IU daily by mouth for 7-12 years
SeleniumDrug
200 mcg daily for 7-12 years
Vitamin E placeboOther
daily for 7-12 years
selenium placeboOther
daily for 7-12 years
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Prostate CancerTime frame: Every six months for 7 to 12 years depending on when the participant was randomized.
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois
Midwest Center for Hematology/Oncology
Joliet, Illinois
Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois
CCOP - Cancer Research for the Ozarks
Springfield, Missouri
St. John's Regional Health Center
Springfield, Missouri
Good Samaritan Hospital Cancer Treatment Center
Cincinnati, Ohio
Bethesda North Hospital
Cincinnati, Ohio
Tod Children's Hospital
Youngstown, Ohio
LaFortune Cancer Center at St. John Medical Center
Tulsa, Oklahoma
Geisinger Medical Center
Danville, Pennsylvania
Geisinger Medical Group - Scenery Park
State College, Pennsylvania
Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
Wilkes-Barre, Pennsylvania
U.T. Cancer Institute at University of Tennessee Medical Center
Knoxville, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.